ASGE Masterclass: Barrett’s Esophagus, GERD and Esophageal Adenocarcinoma (On Demand)

Video Transcription

Video Summary

In this video, the speaker discusses various concerns and questions related to the use of proton pump inhibitors (PPIs) for the treatment of gastroesophageal reflux disease (GERD) and other related conditions. The speaker discusses the challenge of dispelling myths and addressing patient concerns about PPIs. They mention several studies including the Paul Moyaddy studies, the ASPECT trial, and the COMPASS trial, which provide evidence of the efficacy and safety of PPIs. The speaker also highlights the importance of controlling reflux to prevent complications and discusses potential future treatments such as potassium acid blockers. In terms of monitoring, the speaker personally monitors patients' magnesium and creatinine levels annually. The speaker also addresses various questions from the audience, including the use of anti-reflux surgery, management of ongoing bloating with PPI therapy, and the treatment of non-acid reflux and LPR (laryngopharyngeal reflux). The discussion concludes with a conversation about elevated creatinine levels and the importance of communication and collaboration with nephrologists in managing such cases. <br /><br />No credits were granted in the video transcript.

Keywords

proton pump inhibitors

GERD

efficacy

safety

reflux complications